Ping Xie
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Parathyroid Disorders and Treatments
Papers in
-
- Retinal Diseases and Treatments 34
- Glaucoma and retinal disorders 14
- Intraocular Surgery and Lenses 12
- Ocular Diseases and Behçet’s Syndrome 8
-
- Retinal and Macular Surgery 14
- Retinal Imaging and Analysis 10
- Co-authors
- Qinghuai LiuYashpal S. KanwarZizhong HuFarhad R. DaneshLin SunJun WadaSumant S. ChughElisabeth I. Wallner
- Journals
- PLoS ONE (7 papers)Scientific Reports (4 papers)Experimental Eye Research (3 papers)BMC Ophthalmology (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ping Xie
126 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Ophthalmology 650
- Nephrology 462
- Clinical Biochemistry 274
- Neurology 209
- Immunology 507
Countries citing papers authored by Ping Xie
This map shows the geographic impact of Ping Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Xie more than expected).
Fields of papers citing papers by Ping Xie
This network shows the impact of papers produced by Ping Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Xie. The network helps show where Ping Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2020 | 5 | |
| 9 | Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy Trial (CONCEPT)：Effects of preoperativeintravitreal conbercept on cytokines in the vitreous with proliferative diabetic retinopathy | 2019 | 1 |
| 10 | 2015 | 1 | |
| 11 | [Correlation of HLA-DRB1 gene polymorphism and aplastic anemia in Xinjiang Han people]. | 2014 | 2 |
| 12 | 2014 | 11 | |
| 13 | 2012 | 103 | |
| 14 | 2012 | 4 | |
| 15 | 2011 | 28 | |
| 16 | 2010 | 3 | |
| 17 | 2009 | 87 | |
| 18 | 2007 | 223 | |
| 19 | 2005 | 13 | |
| 20 | Treatment of no-reflow phenomenon following percutaneous coronary intervention in 17 patients with acute myocardial infarction | 2004 | 1 |
About Ping Xie
Ping Xie is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Immunology, Transplantation and Neurology, having authored 128 papers that have together received 3.4k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (34 papers), Glaucoma and retinal disorders (14 papers), Retinal and Macular Surgery (14 papers), Intraocular Surgery and Lenses (12 papers), Retinal Development and Disorders (11 papers), Retinal Imaging and Analysis (10 papers), Extracellular vesicles in disease (9 papers) and Ocular Diseases and Behçet’s Syndrome (8 papers). The work is most often cited by research in Ophthalmology (650 citations), Nephrology (462 citations), Clinical Biochemistry (274 citations), Neurology (209 citations) and Immunology (507 citations). Ping Xie has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qinghuai Liu, Yashpal S. Kanwar, Zizhong Hu, Farhad R. Danesh, Lin Sun, Jun Wada, Sumant S. Chugh, Elisabeth I. Wallner, Sheldon Chen and Junli Ding. Their work appears in journals such as PLoS ONE, Scientific Reports, Experimental Eye Research, BMC Ophthalmology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.